Novel 2-aminooxazolines as TAAR1 ligands for CNS disorders

Details for Australian Patent Application No. 2008209860 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Galley, Guido; Stalder, Henri; Norcross, Roger; Groebke Zbinden, Katrin

Agent Spruson & Ferguson

Pub. Number AU-A-2008209860

PCT Pub. Number WO2008/092785

Priority 07101681.0 02.02.07 EP

Filing date 23 January 2008

Wipo publication date 7 August 2008

International Classifications

C07D 263/28 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

6 August 2009 PCT application entered the National Phase

  PCT publication WO2008/092785 Priority application(s): WO2008/092785

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209861-6-oxo-6,7-dihydro-5Hdibenzo[b,d]azepin-7-yl derivatives

2008209857-Injection site for injecting medication